Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
Open Access
- 1 January 2011
- journal article
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 5 (1) , DTI.S6582-32
Abstract
Inhibiting Hsp90 chaperone roles using 17AAG induces cytostasis or apoptosis in tumor cells through destabilization of several mutated cancer promoting proteins. Although mitochondria are central in deciding the fate of cells, 17AAG induced effects on tumor cell mitochondria were largely unknown. Here, we show that Hsp90 inhibition with 17AAG first affects mitochondrial integrity in different human tumor cells, neuroblastoma, cervical cancer and glial cells. Using human neuroblastoma tumor cells, we found the early effects associated with a change in mitochondrial membrane potential, elongation and engorgement of mitochondria because of an increased matrix vacuolization. These effects are specific to Hsp90 inhibition as other chemotherapeutic drugs did not induce similar mitochondrial deformity. Further, the effects are independent of oxidative damage and cytoarchitecture destabilization since cytoskeletal disruptors and mitochondrial metabolic inhibitors also do not induce similar deformity induced by 17AAG. The 1D PAGE LC MS/MS mitochondrial proteome analysis of 17AAG treated human neuroblastoma cells showed a loss of 61% proteins from membrane, metabolic, chaperone and ribonucleoprotein families. About 31 unmapped protein IDs were identified from proteolytic processing map using Swiss-Prot accession number, and converted to the matching gene name searching the ExPASy proteomics server. Our studies display that Hsp90 inhibition effects at first embark on mitochondria of tumor cells and compromise mitochondrial integrity. Abstract non disponibileKeywords
This publication has 57 references indexed in Scilit:
- Preclinical Characterization of Mitochondria-Targeted Small Molecule Hsp90 Inhibitors, Gamitrinibs, in Advanced Prostate CancerClinical Cancer Research, 2010
- The Gene Ontology in 2010: extensions and refinementsNucleic Acids Research, 2009
- Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90Journal of Clinical Investigation, 2009
- Database resources of the National Center for Biotechnology InformationNucleic Acids Research, 2009
- Mitochondrial Swelling Measurement In Situ by Optimized Spatial Filtering: Astrocyte-Neuron DifferencesBiophysical Journal, 2008
- Hsp90 Inhibitors Disrupt Mitochondrial Homeostasis in Cancer CellsChemistry & Biology, 2007
- Hsp90 Inhibition Decreases Mitochondrial Protein TurnoverPLOS ONE, 2007
- Oxidative phosphorylation dysfunction modulates expression of extracellular matrix—remodeling genes and invasionCarcinogenesis, 2005
- The Hallmarks of CancerCell, 2000
- Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA.Molecular Biology of the Cell, 1997